O-GlcNAcylation protein disruption by Thiamet G promotes changes on the GBM U87-MG cells secretome molecular signature

Glioblastoma (GBM) is a grade IV glioma highly aggressive and refractory to the therapeutic approaches currently in use. O-GlcNAcylation plays a key role for tumor aggressiveness and progression in different types of cancer; however, experimental evidence of its involvement in GBM are still lacking....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical proteomics 2021-04, Vol.18 (1), p.14-14, Article 14
Hauptverfasser:	Oliveira-Nunes, Maria Cecilia, Julião, Glaucia, Menezes, Aline, Mariath, Fernanda, Hanover, John A, Evaristo, Joseph Albert Medeiros, Nogueira, Fábio César Sousa, Dias, Wagner Barbosa, de Abreu Pereira, Denise, Carneiro, Katia
Format:	Artikel
Sprache:	eng
Schlagworte:	Development and progression Gliomas Health aspects Proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!